AFP and hepatocellular carcinoma: In addition, unlike previous studies, we also evaluated the diagnostic value of PIVKA-II in the AFP-negative group, the study found that PIVKA-II showed moderate diagnostic ability for AFP-negative patients with HCC, which further proved the complementary role of PIVKA-II for AFP in the diagnosis of HCC.